Form 8-K Skye Bioscience, Inc. For: Oct 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Nasdaq, S&P 500 edge lower as tech stocks drop; focus on Mideast conflict
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices fall to one-week low after US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
Craig-Hallum Downgrades Skye Bioscience (SKYE) to Hold
October 6, 2025 12:11 PM EDTCraig-Hallum analyst Albert Lowe downgraded Skye Bioscience (NASDAQ: SKYE) from Buy to Hold with a price target of $2.00.
For an analyst ratings summary and ratings history on Skye Bioscience click here. For more ratings news on Skye Bioscience click here.
Shares of Skye Bioscience closed at $4.75 yesterday.
... More